Purdue Pharma LP has admitted criminal conduct relating to distribution of its opioid painkillers. The admission comes as part of an agreement between the company and the US Justice Department in which Purdue has agreed to pay $225 million towards resolving legal investigations. As part of the agreement the company must now complete a bankruptcy filing and shift its assets to a ‘public benefit company’. The agreement means that the company will avoid an estimated $8 billion in penalties and that the executives and owners will not face criminal convictions. None of the individuals, however, has been released from criminal liability, with many still under investigation by a separate Justice Department.